Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Circulating gut microbial metabolites and risk of coronary heart disease: A prospective multi-stage metabolomics study.

PLoS medicine·2026

Same author

Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial.

Critical pathways in cardiology·2025

Same author

Circulating gut microbial metabolites and risk of coronary heart disease: a prospective, multi-stage study.

medRxiv : the preprint server for health sciences·2025

Same author

iDDN: determining trans-omics network structure and rewiring with integrative differential dependency networks.

Bioinformatics advances·2025

Same author

Genome-wide association study and multi-ancestry meta-analysis identify common variants associated with carotid artery intima-media thickness.

medRxiv : the preprint server for health sciences·2025

Same author

Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) Trial.

Critical pathways in cardiology·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Cardiovascular genomics: outcomes and implications.

David M Herrington¹

¹Wake Forest University School of Medicine, Internal Medicine/Section on Cardiology, Winston Salem, North Carolina 27157, USA. dherring@wfubmc.edu

The Canadian Journal of Cardiology

|April 14, 2010

Summary

Genomics offers new cardiovascular disease insights, but single nucleotide polymorphisms don't fully predict risk. Family history remains crucial for stratifying risk and guiding prevention strategies.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Related Experiment Videos

Last Updated: Jun 13, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Area of Science:

Cardiovascular genomics
Clinical cardiovascular research

Background:

Genomics technology is revolutionizing cardiovascular disease research.
Genome-wide association studies (GWAS) identify links between genetic variations and cardiovascular phenotypes.

Purpose of the Study:

To evaluate the clinical utility of current genomic findings in cardiovascular disease risk assessment.
To determine if genetic risk alleles are sufficient for patient screening.

Main Methods:

Review of recent genome-wide association studies.
Analysis of the contribution of single nucleotide polymorphisms (SNPs) to cardiovascular disease risk.

Main Results:

GWAS reveal significant associations between SNPs and cardiovascular phenotypes.
Identified risk alleles explain only a small fraction of individual cardiovascular risk, limiting their use in screening.

Conclusions:

Current genomic data, specifically SNPs, are insufficient for individual cardiovascular disease screening.
Clinicians must continue using family history for risk stratification.
Established preventive measures remain paramount for patients at risk of cardiovascular disease.